Oncomark Limited

Where the EU money came from

Funding by EU programme. Amounts are Oncomark Limited's own share of each project, not the project's full budget.

Projects

10 EU-funded projects, newest first. Oncomark Limited led 1 of them as coordinator. Each links to the official record.

• OncoMasTRCoordinator

  OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer

  Horizon 2020 · 2016–2018 · Project on CORDIS ↗

  €2.8Mtheir share
• TOPMed10Partner

  Fellowship Programme supporting Career Development and Interdisciplinary Training in Omics driven Personalised Medicine

  Horizon 2020 · 2015–2021 · Project on CORDIS ↗
• MEL-PLEXPartner

  Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

  Horizon 2020 · 2014–2018 · Project on CORDIS ↗

  €266ktheir share
• SYS-MELPartner

  SYSTEMS-BASED VIEW OF MELANOMA PROGRESSION: TOWARDS NOVEL DIAGNOSTIC (AND THERAPEUTIC) APPLICATIONS

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €738ktheir share
• APO-DECIDEPartner

  Apoptosis Modelling for Treatment Decisions in Colorectal Cancer

  FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

  €508ktheir share
• ANGIOPREDICTPartner

  Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer

  FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

  €698ktheir share
• FAST-PATHPartner

  Fast-Tracking Pathology via Automated Image Analysis and High-Performance Computing: Application to Prostate Cancer Diagnostics

  FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

  €534ktheir share
• RATHERPartner

  Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes

  FP7 (2007 to 2013) · 2011–2018 · Project on CORDIS ↗

  €996ktheir share
• ANGIOTOXPartner

  Histopathologic and Mechanistic Assessment of Angiogenesis Inhibitor Related Toxicities: A Cross-Sectoral, Multi-disciplinary Approach

  FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

  €494ktheir share
• TARGET-MELANOMAPartner

  Molecular Dissection of Melanoma Progression: An integrated Pan-European Approach

  FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

  €795ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• University College Dublin, National University of Ireland, DublinIreland · 8 shared projects
• Royal College of Surgeons In IrelandIreland · 5 shared projects
• Katholieke Universiteit LeuvenBelgium · 3 shared projects
• Uppsala UniversitetSweden · 2 shared projects
• Stichting VuNetherlands · 2 shared projects
• University of StuttgartGermany · 2 shared projects
• Ruprecht-Karls-Universitaet HeidelbergGermany · 2 shared projects
• The Queen'S University of BelfastUnited Kingdom · 2 shared projects
• Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en PatientenzorgNetherlands · 2 shared projects
• Pintail LtdIreland · 2 shared projects
• Beatson Institute for Cancer Research LbgUnited Kingdom · 2 shared projects
• Optimata LtdIsrael · 2 shared projects
• Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 1 shared project
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
• The Hebrew University of JerusalemIsrael · 1 shared project
• Lunds UniversitetSweden · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• RNA
• breast cancer
• cell biology
• cell signaling
• colorectal cancer
• diagnostic technologies
• drug discovery
• epigenetics
• genomes
• graphic design
• innovation management
• mathematical model
• melanoma